SCHEMBL7872258

SCHEMBL7872258

C=CCOC(=O)c1ccccc1OC(=O)/C=C(/C)c1ccc2c(c1)C(C)(C)CCC2(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.43
RXRA P19793 14/20 0.41
RARG P13631 11/20 0.41
RARA P10276 9/20 0.41
RARB P10826 9/20 0.41
ALDH1A1 P00352 2/20 0.41
HSD17B10 Q99714 2/20 0.41
CYP26A1 O43174 2/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
GMNN O75496 1/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
CYP2D6 P10635 1/20 0.41
NFKB1 P19838 1/20 0.41
CYP2C19 P33261 1/20 0.41
THPO P40225 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7872262 1.00 CYP3A4 (0.43) CYP3A4RXRARARGRARARARB
SCHEMBL7878351 0.84 RXRA (0.53) CYP3A4RXRARARGRARARARB
SCHEMBL7878348 0.84 RXRA (0.53) CYP3A4RXRARARGRARARARB
SCHEMBL7872246 0.82 CYP3A4 (0.43) CYP3A4RXRARARGRARARARB
SCHEMBL7872249 0.82 CYP3A4 (0.43) CYP3A4RXRARARGRARARARB
SCHEMBL7898074 0.74 RXRA (0.52) RXRARARGRARARARBCYP26A1
SCHEMBL7566119 0.73 RXRA (0.54) CYP3A4RXRARARGRARARARB
SCHEMBL7565076 0.73 RXRA (0.54) CYP3A4RXRARARGRARARARB
SCHEMBL7872163 0.73 RXRA (0.54) CYP3A4RXRARARGRARARARB
SCHEMBL7872231 0.73 RARB (0.67) CYP3A4RXRARARGRARARARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6326510-B1 SKIN DISORDERS; ANTICANCER AGENTS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2001-12-04 US disclosed